Thứ ba, 29/03/2022 20:49 GMT+7

Từ viết tắt

Xem với cỡ chữ

Đọc bài viết

Tương phản

Vắc xin SARS-COV-2 và những thông tin liên quan (Cập nhật đến 25/3/2022)

Vắc xin đã cứu sống hàng triệu người mỗi năm. Việc phát triển vắc xin COVID-19 an toàn và hiệu quả là một bước tiến lớn trong nỗ lực toàn cầu nhằm chấm dứt đại dịch và để chúng ta quay trở lại cuộc sống bình thường. Để hiểu rõ về tác dụng cũng như những nghiên cứu về vắc xin COVID-19, Cục Thông tin KH&CN quốc gia xin giới thiệu một số bài nghiên cứu đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống. Những nghiên cứu công bố trước đó trong năm 2022 được tổng hợp tại đường link cuối bài.

SCIENCEDIRECT

1. Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)

Vaccine, 10 December 2021, Volume 40, Issue 3 (Cover date: 24 January 2022), Pages 512-520

Mark A. Katz, Efrat Bron Harlev, Ran D. Balicer

https://www.sciencedirect.com/science/article/pii/S0264410X21015802/pdfft?md5=a829e40487d895374102e2175733c242&pid=1-s2.0-S0264410X21015802-main.pdf

2. COVID-19 vaccine guidelines was numerous in quantity but many lack transparent reporting of methodological practices

Journal of Clinical Epidemiology, 14 December 2021, Volume 144 (Cover date: April 2022), Pages 163-172

Zijun Wang, Hui Liu, Yaolong Chen

https://www.sciencedirect.com/science/article/pii/S0895435621004194/pdfft?md5=d6b153c96a9e482a20910809e8b0227a&pid=1-s2.0-S0895435621004194-main.pdf

3. COVID-19 vaccine hesitancy: The effects of combining direct and indirect online opinion cues on psychological reactance to health campaigns

Computers in Human Behavior, 22 October 2021, Volume 127 (Cover date: February 2022), Article 107057

Fangcao Lu, Yanqing Sun

https://www.sciencedirect.com/science/article/pii/S0747563221003800/pdfft?md5=56b73a1a6a8171cfb1ee0d4d52fcb0bf&pid=1-s2.0-S0747563221003800-main.pdf

4. Integration of fuzzy-weighted zero-inconsistency and fuzzy decision by opinion score methods under a q-rung orthopair environment: A distribution case study of COVID-19 vaccine doses

Computer Standards & Interfaces, 25 August 2021, Volume 80 (Cover date: March 2022), Article 103572

A. S. Albahri, O. S. Albahri, M. A. Ahmed

https://www.sciencedirect.com/science/article/pii/S0920548921000672/pdfft?md5=763940c9162e1e9cd71d37d82fe267e0&pid=1-s2.0-S0920548921000672-main.pdf

5. COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales

Vaccine, 15 January 2022, Volume 40, Issue 8 (Cover date: 16 February 2022), Pages 1180-1189

Stuart Bedston, Ashley Akbari, Ronan A. Lyons

https://www.sciencedirect.com/science/article/pii/S0264410X21015358/pdfft?md5=7334a587ddba5da9ee1a84e4ec7cdff2&pid=1-s2.0-S0264410X21015358-main.pdf

6. Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial

The Lancet, 20 January 2022, Volume 399, Issue 10323 (Cover date: 29 January–4 February 2022), Pages 461-472

Lulu BravoIgor Smolenov, Ralf Clemens

https://www.sciencedirect.com/science/article/pii/S0140673622000551/pdfft?md5=8c794797159c6b7baa72b53e23e7839a&pid=1-s2.0-S0140673622000551-main.pdf

7. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

The Lancet Respiratory Medicine, 17 November 2021, Volume 10, Issue 2 (Cover date: February 2022), Pages 167-179

Seth Toback, Eva Galiza, Paul T Heath

https://www.sciencedirect.com/science/article/pii/S2213260021004094/pdfft?md5=868025319e6fa6866c1af0865dbd0774&pid=1-s2.0-S2213260021004094-main.pdf

8. Effectiveness of inactivated COVID-19 vaccines against severe illness in B.1.617.2 (Delta) variant–infected patients in Jiangsu, China

International Journal of Infectious Diseases, 19 January 2022, Volume 116 (Cover date: March 2022), Pages 204-209

Zhiliang Hu, Bilin Tao, Jianming Wang

https://www.sciencedirect.com/science/article/pii/S1201971222000339/pdfft?md5=243821a5bcf29c0bf9a2d53fb665e894&pid=1-s2.0-S1201971222000339-main.pdf

9. Characterizing initial COVID-19 vaccine attitudes among pregnancy-capable healthcare workers

American Journal of Obstetrics & Gynecology MFM, 22 December 2021, Volume 4, Issue 2 (Cover date: March 2022), Article 100557

Marta J. Perez, Rachel Paul, Megan E. Foeller

https://www.sciencedirect.com/science/article/pii/S2589933321002536/pdfft?md5=ce05d216b53769f4a936900b4dff055f&pid=1-s2.0-S2589933321002536-main.pdf

10. Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July–December 2020)

Vaccine, 1 December 2021, Volume 40, Issue 1 (Cover date: 3 January 2022), Pages 151-161

Sara Valckx, Jonas Crèvecoeur, Thomas Neyens

https://www.sciencedirect.com/science/article/pii/S0264410X21014146/pdfft?md5=55628bba1ca80b949f3adf1358cf9308&pid=1-s2.0-S0264410X21014146-main.pdf

11. Experience of the first 1127 COVID-19 Vaccine Allergy Safety patients in Hong Kong - Clinical outcomes, barriers to vaccination, and urgency for reform

World Allergy Organization Journal, 20 December 2021, Volume 15, Issue 1 (Cover date: January 2022), Article 100622

Valerie Chiang, Sabrina Wing Shan Mok, Philip Hei Li

https://www.sciencedirect.com/science/article/pii/S1939455121001162/pdfft?md5=6bb20b73ef890d72fc2ae34ee859f0ed&pid=1-s2.0-S1939455121001162-main.pdf

SPRINGER NATURE

1. Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform

Nawamin Sa-nguanmoo, Katawut Namdee, Mattaka Khongkow, Uracha Ruktanonchai… in Nano Research (2022)

https://link.springer.com/content/pdf/10.1007%2Fs12274-021-3832-y.pdf

2. COVID-19 vaccine development based on recombinant viral and bacterial vector systems: combinatorial effect of adaptive and trained immunityNawamin Sa-nguanmoo, Mi-Hyun Lee, Bum-Joon Kim in Journal of Microbiology (2022)

https://link.springer.com/content/pdf/10.1007%2Fs12275-022-1621-2.pdf

3. Middle East Respiratory Syndrome coronavirus vaccine development: updating clinical studies using platform technologies

Jung-ah Choi, Jae-Ouk Kim in Journal of Microbiology (2022)

https://link.springer.com/content/pdf/10.1007%2Fs12275-022-1547-8.pdf

4. Is vaccine hesitancy justified? Benchmarking post-market vaccine risks with five commonly used medicinal products in Canada

Tuhin Maity, Ahmad von Schlegell, Christopher Longo in Canadian Journal of Public Health (2022)

https://link.springer.com/content/pdf/10.17269%2Fs41997-022-00609-9.pdf

5. Study of the epidemiology of COVID-19 in Ontario elementary and secondary school education workers: an interim analysis following the first school year

Brenda L. Coleman, Kailey Fischer, Robert Maunder… in Canadian Journal of Public Health (2022)

https://link.springer.com/content/pdf/10.17269%2Fs41997-022-00613-z.pdf

6. Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients

Michael Haase, Paul Lesny, Mark Anderson, Gavin Cloherty… in Journal of Nephrology (2022)

https://link.springer.com/content/pdf/10.1007%2Fs40620-022-01247-7.pdf

7. Practice report: an Alberta Métis model for COVID-19 vaccine delivery

Keith D. King, Reagan Bartel, Ashton James… in Canadian Journal of Public Health (2022)

https://link.springer.com/content/pdf/10.17269%2Fs41997-021-00603-7.pdf

8. COVID-19 Vaccination for Frail Older Adults in Singapore - Rapid Evidence Summary and Delphi Consensus Statements

J. Gao, P. Lun, Y. Y. Ding, Pradeep Paul George in The Journal of Frailty & Aging (2022)

https://link.springer.com/content/pdf/10.14283%2Fjfa.2022.12.pdf

Các công bố về COVID-19 trước thời gian trên:

Cập nhật các công bố về COVID-19 từ ngày 11/03 đến ngày 18/03/2022

https://vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/nhung-thong-tin-ve-sars-cov-2-hien-nay-ngay-11-3-18-3-2022-4778.html

Cập nhật các công bố về COVID-19 từ ngày 04/03 đến ngày 11/03/2022